Today’s guest post comes from Trygve Anderson, Vice President of Commercial Pharmacy at Elsevier.
Trygve discusses trends and challenges to watch in 2020, including drug pricing transparency, the approval and interchangeability of biosimilars, and stakeholder access to timely and accurate data.
Learn more about Elsevier’s information analytics capabilities from its video: Evaluating Drug Data Yields Business Value.
Read on for Trygve’s insights.
Read more »
Source: Post feed
